サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1684364

医薬品添加剤の世界市場：製品別・機能別・剤形別・用途別・国別・地域別 - 産業分析、市場規模・シェア、将来予測 (2025年～2032年)

Pharmaceutical Excipients Market, By Product, By Functionality, By Formulation, By Application, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2025-2032

出版日
ページ情報
英文 303 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
医薬品添加剤の世界市場：製品別・機能別・剤形別・用途別・国別・地域別 - 産業分析、市場規模・シェア、将来予測 (2025年～2032年)
出版日: 2025年03月04日
発行: AnalystView Market Insights
ページ情報: 英文 303 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

レポートハイライト

医薬品添加剤の市場規模は2024年に102億3,743万米ドルとなり、2025年から2032年にかけてCAGR 6.96%で拡大

医薬品添加剤の市場力学

新規ドラッグデリバリーシステムとバイオ医薬品に対する需要の高まりが市場需要を促進する見込み

医薬品添加剤市場は、製薬産業の拡大、薬剤製剤の進歩、新規ドラッグデリバリーシステムなど様々な要因によって大きな成長を遂げています。従来の製剤は徐々に、放出制御、徐放、標的薬物送達などの新規ドラッグデリバリーシステム（NDDS）に取って代わられつつあります。これらの高度なドラッグデリバリーシステムは、適切な薬物放出、安定性、有効性を確保するために特殊な賦形剤を必要とします。ポリマーや脂質のような賦形剤は、薬物のバイオアベイラビリティを改善し、投与回数を減らす放出制御型製剤の開発において極めて重要です。さらに、中国、インド、ブラジルなどの新興市場は、製造コストの低下と政府の好意的な政策により、医薬品製造において力強い成長を目の当たりにしています。

スクロース、トレハロース、マンニトールなどの賦形剤は、安定性を維持するために凍結乾燥生物製剤に使用されます。したがって、バイオ医薬品の需要が増加し続けるにつれて、これらの複雑な製剤用に調整された革新的な賦形剤の必要性も高まっています。さらに、米国食品医薬品局（FDA）、欧州医薬品庁（EMA）、国際整合化会議（ICH）などの規制機関は、医薬品の製剤化、安全性、品質に関する厳格なガイドラインを実施しています。これらの基準を満たすため、製薬会社は医薬品の安定性と安全性を高める高品質で適合性の高い賦形剤に注力しています。

医薬品添加剤市場：主な考察

弊社のリサーチアナリストの分析によると、世界市場は予測期間（2025-2032年）に約6.96%のCAGRで毎年成長すると推定されています。

製品別では、有機化学品セグメントは、ジェネリック医薬品からの高い需要のため、2024年に最大の市場シェアを示すと予測されました。

機能別では、経口固形製剤のニーズが高いことから、2024年には潤滑剤・滑剤セグメントが機能性セグメントをリードしました。

剤形別では、カプセル剤、液剤の需要が高いことから、経口剤が2024年の主要剤形となりました。

用途別では、バイオ医薬品で安定剤のニーズが高いことから、2024年の用途別では安定剤セグメントがトップでした。

地域別では、製薬企業が多く存在するアジア太平洋地域が2024年の主要収益源となりました。

医薬品添加剤市場：セグメンテーション分析

世界の医薬品添加剤市場は、製品、機能、製剤、用途、地域によって区分されます。

市場は製品別に有機と無機の2つに分けられます。有機セグメントが市場を独占しています。生物学的製剤、新規ドラッグデリバリーへの需要の高まりが市場成長を後押しすると予想されます。

市場は機能に基づいて7つのカテゴリーに分類されます：充填剤、結合剤、コーティング剤、着色剤、崩壊剤、潤滑剤・滑剤、その他です。潤滑剤・滑剤は経口剤の需要が高いため、最大シェアを占めると予想されます。

市場は剤形によって、経口、局所、非経口、その他の4つに分類されます。最も大きなシェアを占めるのは経口剤です。幅広い用途とさまざまな疾患に対する有効性が、同分野の需要に寄与しています。

市場は用途別に3つのカテゴリーに分類されます：安定剤、味覚マスキング、その他。用途別では安定剤が最も高いシェアを占めています。ジェネリック医薬品の生産、高品質の賦形剤の需要の増加がセグメントの成長を加速させています。

医薬品添加剤市場：地域別分析

世界の医薬品添加剤市場は、北米、ラテンアメリカ、欧州、アジア太平洋、中東アフリカの各地域に広がっています。北米は世界の医薬品添加剤市場を独占しています。米国は、多くのジェネリック医薬品メーカーやバイオ製薬会社を含む強力な製薬セクターの本拠地です。これが賦形剤需要の拡大に寄与しています。欧州は革新的な製剤の最前線にあり、特にバイオ医薬品やワクチンの分野では特殊な賦形剤が必要とされます。欧州では高齢化が進んでおり、慢性疾患に対応する医薬品へのニーズが高まっており、特に経口剤の製剤において医薬品賦形剤の需要を牽引しています。アジア太平洋は、特にインドと中国において、医薬品の受託製造の拠点となりつつあります。

医薬品添加剤市場：競合情勢

医薬品添加剤市場は競争が激しく、数多くの世界企業や地域企業が幅広い種類の添加剤の製造・供給に携わっています。これらの賦形剤は医薬品の製剤化において重要な役割を果たし、安定性やバイオアベイラビリティを向上させる。市場各社は、放出制御剤、バイオアベイラビリティ向上剤、薬物可溶化剤など、多種多様な製剤に使用される賦形剤の提供に注力しています。各社は、薬剤の性能を向上させる新しい賦形剤を開発するための研究開発と技術革新に注力しています。徐放性、放出制御性、バイオアベイラビリティの向上を可能にする賦形剤の需要は高いです。同社は強力な研究開発（R&D）能力を有しているため、顧客に合わせたソリューションを提供することができます。

目次

第1章 医薬品添加剤市場の概要

  • 調査範囲
  • 市場推定期間

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 医薬品添加剤の主な市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 医薬品添加剤市場：産業分析

  • PEST分析
  • ポーターのファイブフォース分析
  • 市場成長の見通し：マッピング
  • 規制体制の分析

第5章 医薬品添加剤市場：高まる地政学的緊張の影響

  • COVID-19パンデミックの影響
  • ロシア・ウクライナ戦争の影響
  • 中東紛争の影響

第6章 医薬品添加剤の市場情勢

  • 医薬品添加剤の市場シェア分析 (2024年)
  • 主要メーカー別の内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 医薬品添加剤市場：製品別

  • 概要
    • セグメント別シェア分析：製品別
    • 有機
    • 無機

第8章 医薬品添加剤市場：機能別

  • 概要
    • セグメント別シェア分析：機能別
    • フィラー
    • バインダー
    • コーティング剤
    • 着色剤
    • 崩壊剤
    • 潤滑剤・滑剤
    • その他

第9章 医薬品添加剤市場：剤形別

  • 概要
    • セグメント別シェア分析：剤形別
    • 経口
    • 局所
    • 非経口
    • その他

第10章 医薬品添加剤市場：用途別

  • 概要
    • セグメント別シェア分析：用途別
    • 安定剤
    • 味覚マスキング
    • その他

第11章 医薬品添加剤市場：地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • オランダ
    • スウェーデン
    • ロシア
    • ポーランド
    • その他
  • アジア太平洋（APAC）
    • 概要
    • アジア太平洋地域の主要メーカー
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • インドネシア
    • タイ
    • フィリピン
    • その他
  • ラテンアメリカ（LATAM）
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東およびアフリカ（MEA）
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第12章 主要ベンダー分析：医薬品添加剤業界

  • 競合ダッシュボード
    • 競合ベンチマーク
    • 競合ポジショニング
  • 企業プロファイル
    • Dow Inc.
    • Evonik Industries AG
    • BASF SE
    • Lubrizol Corporation
    • FMC Corporation
    • Roquette Freres
    • Sinopharm Group Co., Ltd.
    • Wacker Chemie AG
    • Shin-Etsu Chemical Co., Ltd.
    • InnoBio Limited
    • Ashland Global Holdings Inc.
    • Cargill, Inc.
    • JRS PHARMA GmbH &Co. KG
    • Mitsubishi Chemical Corporation
    • ARCH Chemicals, Inc.
    • Others

第13章 AnalystViewの全方位的分析

目次
Product Code: ANV4833

REPORT HIGHLIGHT

Pharmaceutical Excipients Market size was valued at USD 10,237.43 Million in 2024, expanding to a CAGR of 6.96% from 2025 to 2032.

Pharmaceutical excipients are inactive substances formulated alongside the active pharmaceutical ingredient (API) in a drug. They serve various roles, such as aiding in drug delivery, enhancing stability, improving taste, and ensuring proper manufacturing.

Pharmaceutical Excipients Market- Market Dynamics

Rising demand for novel drugs delivery systems and biopharmaceuticals is expected to propel market demand

The pharmaceutical excipients market is experiencing significant growth, driven by various factors including the expansion of the pharmaceutical industry, advancements in drug formulations, and novel drug delivery systems. Traditional drug formulations are gradually being replaced by novel drug delivery systems (NDDS) such as controlled-release, sustained-release, and targeted drug delivery. These advanced drug delivery systems require specialized excipients to ensure proper drug release, stability, and effectiveness. Excipients like polymers and lipids are crucial in developing controlled-release formulations, which improve drug bioavailability and reduce dosing frequency. Additionally, emerging markets such as China, India, and Brazil are witnessing strong growth in pharmaceutical manufacturing due to lower production costs and favorable government policies.

Excipients such as sucrose, trehalose, and mannitol are used in freeze-dried biologics to maintain stability. Thus, as the demand for biopharmaceuticals continues to rise, so does the need for innovative excipients tailored for these complex formulations. Further, regulatory bodies such as the U.S. Food and Drug Administration (FDA), European Medicines Agency (EMA), and International Council for Harmonisation (ICH) enforce strict guidelines on drug formulation, safety, and quality. To meet these standards, pharmaceutical companies are focusing on high-quality, compliant excipients that enhance drug stability and safety.

Pharmaceutical Excipients Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 6.96% over the forecast period (2025-2032)

Based on Product segmentation, the organic chemicals segment was predicted to show maximum market share in the year 2024, due to high demand from generic drugs.

Based on Functionality segmentation, the lubricants & glidants segment was the leading Functionality segment in 2024, due to the high need of oral solid dosages.

Based on Formulation segmentation, the oral segment was the leading Formulation segment in 2024, owing to high demand from capsule, liquid formulations.

Based on Application segmentation, the stabilizers segment was the leading Application segment in 2024, owing to high need for stabilizers in biopharmaceuticals.

On the basis of the region, Asia Pacific was the leading revenue generator in 2024, owing to large presence of pharmaceutical companies.

Pharmaceutical Excipients Market- Segmentation Analysis:

The Global Pharmaceutical Excipients Market is segmented on the basis of Product, Functionality, Formulation, Application, and Region.

The market is divided into two categories based on Product: organic and inorganic. The organic segment dominates the market. The increasing demand for biological drugs, novel drug delivery is expected to boost market growth.

The market is divided into seven categories based on the Functionality: fillers, binders, coating agents, colorants, disintegrants, lubricants & glidants, and others. The lubricants & glidants segment is expected to hold the largest share due to the high demand from oral dosages.

The market is divided into four categories based on Formulation: oral, topical, parenteral, and others. The oral segment is expected to hold the largest share. The wider usage & its efficacy against different ailments is contributing to segment demand.

The market is divided into three categories based on Application: stabilizers, taste masking, and others. The stabilizers segment holds the highest share of the application segment. The increasing demand from generic drug production, high quality excipients is accelerating segment growth.

Pharmaceutical Excipients Market- Geographical Insights

Across the world, the Pharmaceutical Excipients market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. North America dominates the global pharmaceutical excipients market. The U.S. is home to a robust pharmaceutical sector, including many generic drug manufacturers and biopharmaceutical companies. This contributes to the growing demand for excipients. Europe is at the forefront of innovative drug formulations, particularly in the areas of biopharmaceuticals and vaccines, which require specialized excipients. With an aging population in Europe, there is a growing need for drugs that cater to chronic diseases, driving the demand for pharmaceutical excipients, especially in oral drug formulations. Asia-Pacific is becoming a hub for contract manufacturing of pharmaceuticals, particularly in India and China.

Pharmaceutical Excipients Market- Competitive Landscape:

The pharmaceutical excipients market is highly competitive, with numerous global and regional players engaged in the production and supply of a wide range of excipients. These excipients play a critical role in drug formulation, enhancing stability, bioavailability. Market players focus on offering excipients that are used in a wide variety of drug formulations, including controlled-release, bioavailability enhancers, and drug solubilizers. Companies are focusing on R&D and innovation to develop new excipients that improve drug performance. Excipients that can enable sustained-release, controlled-release, and bioavailability enhancement are in high demand. The company's strong research and development (R&D) capabilities allow it to offer tailored solutions for customers.

Recent Developments:

In 2023, BASF collaborated with Croda International Plc to develop and market new excipients aimed at improving drug delivery in oral and parenteral formulations.

In 2024, Roquette Freres has focused on developing plant-based excipients that cater to the growing consumer preference for natural ingredients.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET KEY PLAYERS

  • Dow Inc.
  • Evonik Industries AG
  • BASF SE
  • Lubrizol Corporation
  • FMC Corporation
  • Roquette Freres
  • Sinopharm Group Co., Ltd.
  • Wacker Chemie AG
  • Shin-Etsu Chemical Co., Ltd.
  • InnoBio Limited
  • Ashland Global Holdings Inc.
  • Cargill, Inc.
  • JRS PHARMA GmbH & Co. KG
  • Mitsubishi Chemical Corporation
  • ARCH Chemicals, Inc.
  • Others

GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT- MARKET ANALYSIS, 2019-2032

  • Organic
  • Inorganic

GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY- MARKET ANALYSIS, 2019-2032

  • Fillers
  • Binders
  • Coating agents
  • Colorants
  • Disintegrants
  • Lubricants & glidants
  • Others

GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION- MARKET ANALYSIS, 2019-2032

  • Oral
  • Topical
  • Parenteral
  • Others

GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019-2032

  • Stabilizers
  • Taste masking
  • Others

GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET, BY REGION- MARKET ANALYSIS, 2019-2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Pharmaceutical Excipients Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Pharmaceutical Excipients Market Snippet by Product
    • 2.1.2. Pharmaceutical Excipients Market Snippet by Functionality
    • 2.1.3. Pharmaceutical Excipients Market Snippet by Formulation
    • 2.1.4. Pharmaceutical Excipients Market Snippet by Application
    • 2.1.5. Pharmaceutical Excipients Market Snippet by Country
    • 2.1.6. Pharmaceutical Excipients Market Snippet by Region
  • 2.2. Competitive Insights

3. Pharmaceutical Excipients Key Market Trends

  • 3.1. Pharmaceutical Excipients Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Pharmaceutical Excipients Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Pharmaceutical Excipients Market Opportunities
  • 3.4. Pharmaceutical Excipients Market Future Trends

4. Pharmaceutical Excipients Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Pharmaceutical Excipients Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Pharmaceutical Excipients Market Landscape

  • 6.1. Pharmaceutical Excipients Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Pharmaceutical Excipients Market - By Product

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product, 2024 & 2032 (%)
    • 7.1.2. Organic
    • 7.1.3. Inorganic

8. Pharmaceutical Excipients Market - By Functionality

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Functionality, 2024 & 2032 (%)
    • 8.1.2. Fillers
    • 8.1.3. Binders
    • 8.1.4. Coating agents
    • 8.1.5. Colorants
    • 8.1.6. Disintegrants
    • 8.1.7. Lubricants & glidants
    • 8.1.8. Others

9. Pharmaceutical Excipients Market - By Formulation

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Formulation, 2024 & 2032 (%)
    • 9.1.2. Oral
    • 9.1.3. Topical
    • 9.1.4. Parenteral
    • 9.1.5. Others

10. Pharmaceutical Excipients Market - By Application

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Functionality, 2024 & 2032 (%)
    • 10.1.2. Stabilizers
    • 10.1.3. Taste masking
    • 10.1.4. Others

11. Pharmaceutical Excipients Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Pharmaceutical Excipients Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Functionality, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Functionality, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Functionality, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Pharmaceutical Excipients Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Functionality, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Functionality, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.9. UK
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. UK Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.9.4. UK Market Size and Forecast, By Functionality, 2019 - 2032 (US$ Million)
      • 11.3.9.5. UK Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
      • 11.3.9.6. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.10. France
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. France Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.10.4. France Market Size and Forecast, By Functionality, 2019 - 2032 (US$ Million)
      • 11.3.10.5. France Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
      • 11.3.10.6. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.11. Italy
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. Italy Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.11.4. Italy Market Size and Forecast, By Functionality, 2019 - 2032 (US$ Million)
      • 11.3.11.5. Italy Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
      • 11.3.11.6. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.12. Spain
      • 11.3.12.1. Overview
      • 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.3. Spain Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Spain Market Size and Forecast, By Functionality, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Spain Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
      • 11.3.12.6. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.13. The Netherlands
      • 11.3.13.1. Overview
      • 11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.3. The Netherlands Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.13.4. The Netherlands Market Size and Forecast, By Functionality, 2019 - 2032 (US$ Million)
      • 11.3.13.5. The Netherlands Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
      • 11.3.13.6. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Overview
      • 11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Functionality, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
      • 11.3.14.6. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.15. Russia
      • 11.3.15.1. Overview
      • 11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.3. Russia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Russia Market Size and Forecast, By Functionality, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Russia Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
      • 11.3.15.6. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.16. Poland
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Poland Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Poland Market Size and Forecast, By Functionality, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Poland Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.17. Rest of Europe
      • 11.3.17.1. Overview
      • 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.17.3. Rest of the Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.17.4. Rest of the Europe Market Size and Forecast, By Functionality, 2019 - 2032 (US$ Million)
      • 11.3.17.5. Rest of the Europe Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
      • 11.3.17.6. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Pharmaceutical Excipients Key Manufacturers in Asia Pacific
    • 11.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.4.5. APAC Market Size and Forecast, By Functionality, 2019 - 2032 (US$ Million)
    • 11.4.6. APAC Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
    • 11.4.7. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.8. China
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. China Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.8.4. China Market Size and Forecast, By Functionality, 2019 - 2032 (US$ Million)
      • 11.4.8.5. China Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
      • 11.4.8.6. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.9. India
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. India Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.9.4. India Market Size and Forecast, By Functionality, 2019 - 2032 (US$ Million)
      • 11.4.9.5. India Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
      • 11.4.9.6. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Functionality, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Functionality, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Functionality, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.13. Indonesia
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Indonesia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Indonesia Market Size and Forecast, By Functionality, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Indonesia Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.14. Thailand
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Thailand Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Thailand Market Size and Forecast, By Functionality, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Thailand Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Functionality, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Functionality, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 11.5. Latin America (LATAM)
    • 11.5.1. Overview
    • 11.5.2. Pharmaceutical Excipients Key Manufacturers in Latin America
    • 11.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.5.5. LATAM Market Size and Forecast, By Functionality, 2019 - 2032 (US$ Million)
    • 11.5.6. LATAM Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
    • 11.5.7. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Functionality, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Functionality, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Functionality, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Functionality, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Functionality, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa (MEA)
    • 11.6.1. Overview
    • 11.6.2. Pharmaceutical Excipients Key Manufacturers in Middle East and Africa
    • 11.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.6.5. MEA Market Size and Forecast, By Functionality, 2019 - 2032 (US$ Million)
    • 11.6.6. MEA Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
    • 11.6.7. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Functionality, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Functionality, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Functionality, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Functionality, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Functionality, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Functionality, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Functionality, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Pharmaceutical Excipients Industry

  • 12.1. Competitive Dashboard
    • 12.1.1. Competitive Benchmarking
    • 12.1.2. Competitive Positioning
  • 12.2. Company Profiles
    • 12.2.1. Dow Inc.
    • 12.2.2. Evonik Industries AG
    • 12.2.3. BASF SE
    • 12.2.4. Lubrizol Corporation
    • 12.2.5. FMC Corporation
    • 12.2.6. Roquette Freres
    • 12.2.7. Sinopharm Group Co., Ltd.
    • 12.2.8. Wacker Chemie AG
    • 12.2.9. Shin-Etsu Chemical Co., Ltd.
    • 12.2.10. InnoBio Limited
    • 12.2.11. Ashland Global Holdings Inc.
    • 12.2.12. Cargill, Inc.
    • 12.2.13. JRS PHARMA GmbH & Co. KG
    • 12.2.14. Mitsubishi Chemical Corporation
    • 12.2.15. ARCH Chemicals, Inc.
    • 12.2.16. Others

13. 360 Degree AnalystView

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us